HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,977-2,988 of 4,505
Drug study icon
TerminatedNCT01177709

Metformin for Weight Loss in Schizophrenia

Official study title

Evaluation of the Efficacy of Metformin for Weight Loss and Metabolic Effects In Overweight Psychiatric Patients Treated With Antipsychotic Medication

This study ended early.

In New York
SchizophreniaMedication studyAges 18–70
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Drug study icon
CompletedNCT00711464

Modafinil Effects on Cognition in Schizophrenia Patients

Official study title

A Dose-response Study of Modafinil Effects on Cognition in Schizophrenia Patients.

This study has finished and is no longer accepting participants.

Multiple locations, including Los Angeles
SchizophreniaMedication studyAges 18–54
Countries
United States
Sponsor
University of California, Los Angeles
Other study type icon
CompletedNCT04141540

Molecular Variants Associated With Schizophrenia: Differential Analysis of Monozygotic Twins With Variable Phenotypic 22q11

Official study title

Translational 22q11.2:"Molecular Variants Associated With Schizophrenia: Differential Analysis of Monozygotic Twins With Variable Phenotypic 22q11.2 Microdeletional Syndrom"

This study has finished and is no longer accepting participants.

In Lyon
SchizophreniaInterventional studyAges 18–45
Countries
France
Sponsor
Hôpital le Vinatier
Drug study icon
CompletedNCT02194933

Monotherapy Brexpiprazole (OPC-34712) study in the Treatment of Adults With Schizophrenia With Impulsivity

Official study title

Protocol 331-13-009: An Exploratory, Multicenter, Randomized, Double-Blind, fMRI Study of Fixed-dose Brexpiprazole (OPC-34712) (2 and 4 mg/Day Tablets) in Adults With Schizophrenia With Impulsivity

This study has finished and is no longer accepting participants.

In Orange
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Behavioral study icon
CompletedNCT04941352

Motivational Interviewing in people with Schizophrenia

Official study title

The Effect of Interpersonal Relations Theory-Based Motivational Interviews on Functional Recovery and Insight Levels of Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Denizli
SchizophreniaBehavioural studyAges 18–65
Countries
Türkiye
Sponsor
Pamukkale University
Behavioral study icon
CompletedNCT02413164

Multimodal Physical Therapy Program in Schizophrenia

Official study title

Effectiveness of a Multimodal Physical Therapy Program on Clinical Symptomatology and Physical Fitness in Persons With Schizophrenia

This study has finished and is no longer accepting participants.

In Málaga
SchizophreniaInterventional studyAges 18–60
Countries
Spain
Sponsor
University of Malaga

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.